Literature DB >> 34180640

Tracing Angiotensin II's Yin -Yang effects on cardiovascular-renal pathophysiology. Yin and yang systems of Ang II.

Verdiana Ravarotto1, Giovanni Bertoldi1, Matteo Rigato1, Elisa Pagnin1, Laura Gobbi1, Paul A Davis2, Lorenzo A Calò3.   

Abstract

Adverse changes in cardiovascular and renal systems are major contributors to overall morbidity and mortality. Human cardiovascular and renal systems exhibit a complex network of positive and negative feedback that is reflected in the control of vascular tone via angiotensin II (Ang II) based signaling. This review will examine in some depth, the multiple components and processes that control the status and reflect the health of these various cardiovascular and renal systems, such as pathways associated to monomeric G proteins, RhoA/Rho kinase system and ERK, oxidative stress and NO balance. It will specifically emphasize the "yin-yang" nature of Ang II signaling by comparing and contrasting the effects and activity of various systems, pathways and components found in hypertension to those found in Gitelman's and Bartter's syndromes (GS/BS), two rare autosomal recessive tubulopathies characterized by electrolytic imbalance, metabolic alkalosis, sodium wasting and prominent activation of the renin-angiotensin-aldosterone system. Notwithstanding the activation of the renin-angiotensin-aldosterone system, GS/BS are normo-hypotensive and protected from cardiovascular-renal remodeling and therefore can be considered the mirror image, the opposite of hypertension.

Entities:  

Year:  2021        PMID: 34180640     DOI: 10.23736/S0026-4806.21.07440-1

Source DB:  PubMed          Journal:  Minerva Med        ISSN: 0026-4806            Impact factor:   4.806


  1 in total

1.  Magnesium is crucial in renal-cardiovascular fibrosis but the Gitelman's syndrome paradox still awaits resolution.

Authors:  Lucia Federica Stefanelli; Valentina Di Vico; Paul A Davis; Lorenzo A Calò
Journal:  Int Urol Nephrol       Date:  2022-08-04       Impact factor: 2.266

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.